The goal of the Lab is to develop new treatments and work towards a cure for epilepsy and other neurodevelopmental disorders using a range of innovative approaches in experimental systems.
The Lab studies mechanisms of cerebral cortical circuit function and circuit dysfunction in neurodevelopmental disorders. Investigators in the lab use mouse and human genetics, electrophysiology, pharmacology, imaging, optogenetics, and behavior, in a range of experimental model systems ranging from heterologous cells in culture, neurons generated from induced pluripotent stem (iPS) cells from human patients, and ex vivo and in vivo in animal models of human disease. The lab is particularly interested in the function of a prominent subtype of neuron known as the GABAergic inhibitory interneuron and the role of interneuron dysfunction as a cause of disease.
News from the Lab
Kevin Goff attends the Ion Channels in Synaptic and Neural Circuit Physiology at Cold Spring Harbor Laboratory
June 5 – 25, 2018
Joanna Mattis received an NIH NINDS R25 grant February 6, 2018. Nate Sotuyo received an NRSA F30 from NINDS June 1, 2018.
We found that de novo heterozygous variants in SCN3A are a novel cause of early infantile epileptic encephalopathy.